Africa

                                                                                In Our Hands LONDON, Sept. 17, 2024 (GLOBE NEWSWIRE) — Survivors, experts and advocates from […]

SAN JOSE, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) — Today, Zoom announced that The Federal Risk and Authorization Management Program (FedRAMP®) Joint Authorization Board (JAB) authorized Zoom AI Companion as a JAB Moderate system, adding to Zoom for Government’s growing list of authorized products, solidifying the company’s commitment to the U.S. government space. Most recently, Zoom Contact Center also received […]

11x Series A Announcement – Landscape SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) — 11x, a pioneering AI startup transforming the modern workforce with autonomous digital workers, announced closing a $24 million Series A funding round today. The round was led by Benchmark, with participation from Quiet Capital, SV Angel, Abstract Ventures, Lux Capital, Operator Partners, […]

PARIS and LONDON and NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Akur8, the machine learning-powered insurance pricing and reserving platform, announced today that it has secured $120 million in series C funding, bringing its total raised investment to $180 million. This latest funding round was led by One Peak, a leading growth equity firm […]

Deriv’s client-first philosophy earns the ‘Best Customer Service’ award at the Global Forex Awards, coinciding with its 25th year of empowering traders. 2024 is the year of wins for Deriv, which earlier this year won the ‘Most Trusted Broker’, ‘Best Trading Experience’ (LATAM) 2024, and ‘Best Latam Region Broker’ awards. Deriv receives Best Customer Service […]

AI-Media and Speechmatics Partnership BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in speech recognition technology, today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market. […]

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]